230 related articles for article (PubMed ID: 31812989)
1. Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.
Ferguson TF; Rosen E; Carr R; Brashear M; Simon L; Theall KP; Ronis MJ; Welsh DA; Molina PE
Alcohol Alcohol; 2020 Feb; 55(1):28-36. PubMed ID: 31812989
[TBL] [Abstract][Full Text] [Related]
2. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
Fuster D; Tsui JI; Cheng DM; Quinn EK; Bridden C; Nunes D; Libman H; Saitz R; Samet JH
Alcohol Clin Exp Res; 2013 Sep; 37(9):1527-35. PubMed ID: 23647488
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Assessment of Alcohol Consumption in People Living with HIV (PLWH): The New Orleans Alcohol Use in HIV Study.
Ferguson TF; Theall KP; Brashear M; Maffei V; Beauchamp A; Siggins RW; Simon L; Mercante D; Nelson S; Welsh DA; Molina PE
Alcohol Clin Exp Res; 2020 Jun; 44(6):1261-1272. PubMed ID: 32441814
[TBL] [Abstract][Full Text] [Related]
4. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
5. Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.
Bilal U; Lau B; Lazo M; McCaul ME; Hutton HE; Sulkowski MS; Moore RD; Chander G
AIDS Patient Care STDS; 2016 May; 30(5):200-7. PubMed ID: 27158847
[TBL] [Abstract][Full Text] [Related]
6. The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.
Kim HN; Crane HM; Rodriguez CV; Van Rompaey S; Mayer KH; Christopoulos K; Napravnik S; Chander G; Hutton H; McCaul ME; Cachay ER; Mugavero MJ; Moore R; Geng E; Eron JJ; Saag MS; Merrill JO; Kitahata MM
AIDS Behav; 2017 Jul; 21(7):1878-1884. PubMed ID: 28035496
[TBL] [Abstract][Full Text] [Related]
7. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
[TBL] [Abstract][Full Text] [Related]
8. Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C.
Muga R; Sanvisens A; Fuster D; Tor J; Martínez E; Pérez-Hoyos S; Muñoz A
PLoS One; 2012; 7(10):e46810. PubMed ID: 23056462
[TBL] [Abstract][Full Text] [Related]
9. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?
Sanvisens A; Muñoz A; Bolao F; Zuluaga P; Farré M; Jarrin I; Tor J; Muga R
Drug Alcohol Depend; 2018 Jul; 188():180-186. PubMed ID: 29778771
[TBL] [Abstract][Full Text] [Related]
10. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia.
Barocas JA; So-Armah K; Cheng DM; Lioznov D; Baum M; Gallagher K; Fuster D; Gnatienko N; Krupitsky E; Freiberg MS; Samet JH
PLoS One; 2019; 14(6):e0218852. PubMed ID: 31246992
[TBL] [Abstract][Full Text] [Related]
11. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
[TBL] [Abstract][Full Text] [Related]
13. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
14. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
16. Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.
Chaudhry AA; Sulkowski MS; Chander G; Moore RD
HIV Med; 2009 Mar; 10(3):133-42. PubMed ID: 19207596
[TBL] [Abstract][Full Text] [Related]
17. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
[TBL] [Abstract][Full Text] [Related]
19. Nonviral Liver Disease Burden in People Living With HIV and Elevated Transaminases: A Cross-Sectional Study.
Katarey D; Tan Y; Mourad A; Potts JR; Vickers L; Beksinska A; Sharp H; Parnell B; Gilleece Y; Verma S
J Acquir Immune Defic Syndr; 2024 Jan; 95(1):97-106. PubMed ID: 37831608
[TBL] [Abstract][Full Text] [Related]
20. Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors.
O'Hara G; Mokaya J; Hau JP; Downs LO; McNaughton AL; Karabarinde A; Asiki G; Seeley J; Matthews PC; Newton R
BMJ Open; 2020 Mar; 10(3):e032890. PubMed ID: 32234740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]